Please use this identifier to cite or link to this item:
|Title:||O6-methylguanine-DNA methyltransferase in human brain tumors detected by activity assay and monoclonal antibodies||Authors:||Citron, M.
|Issue Date:||1995||Citation:||Citron, M.,White, A.,Decker, R.,Wasserman, P.,Li, B.,Randall, T.,Guerra, D.,Belanich, M.,Yarosh, D. (1995). O6-methylguanine-DNA methyltransferase in human brain tumors detected by activity assay and monoclonal antibodies. Oncology Research 7 (1) : 49-55. ScholarBank@NUS Repository.||Abstract:||O6-methylguanine-DNA methyltransferase (MGMT) activity was measured in 68 tissue samples taken from brain. A wide range in activity among samples was observed, with all nonmalignant samples showing transferase activity (Mer+) but approximately 15% of WHO grade II low-grade astrocytomas and WHO grade IV glioblastoma multiformes lacking activity (Mer-). On average, astrocytomas and glioblastomas showed less transferase activity than either nonmalignant tissue or meningiomas. Monoclonal antibodies specific for MGMT showed both cytoplasmic and nuclear staining of Mer+ brain tumor cells in culture but no staining of Mer- cells in culture. In pathology specimens from anaplastic astrocytomas, glioblastoma multiformes, and meningiomas, antibody staining revealed both cytoplasmic and nuclear MGMT, while one sample showed little or no MGMT-specific staining. These results help explain why nitrosoureas have been among the most successful agents in treatment of brain tumors and indicate the subcellular localization for the repair activity, which may be relevant to nitrosourea resistance. © 1995.||Source Title:||Oncology Research||URI:||http://scholarbank.nus.edu.sg/handle/10635/112003||ISSN:||09650407|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Apr 11, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.